Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Banc of California (BANC) looks ripe for a mid-term pullback. The stock trades below its short- and medium-term moving averages, EPS is negative, and short interest has been climbing. Combine those technicals with an elevated enterprise value versus market cap and thin cash per share, and the risk/reward favors a tactical short into the $15 area. T…
Origin Agritech Limited announced the sale of its 70.5% equity interest in its Xinjiang Originbo seed production base to Hunan Xindaxin Limited for approximately US$15 million. Concurrently, a five-year lease-back agreement ensures operational continuity at the production facility, preserving seed supply stability. The proceeds will be deployed to …
Anfield Energy received approval from the Colorado Division of Reclamation, Mining and Safety on the reclamation permit application for its JD-8 uranium and vanadium mine, a key asset in Anfield's Monogram Mesa Mine Complex. The decision clears state-level permitting, with federal approvals underway, targeting a restart of production by mid-2027. T…
USA Rare Earth, a Nasdaq-listed rare earth and critical minerals company, has completed its CEO succession with Thras Moraitis stepping into the role. Moraitis aims to integrate the company's diverse operations across mining, processing, and magnet manufacturing in the US, Brazil, and UK. The company is structured into three business units to enhan…
BioStem Technologies, Inc., a regenerative medicine company, announced the issuance of a new U.S. patent and multiple patent allowances in the U.S. and Mexico covering its placental and umbilical tissue allograft technologies. These patents focus on wound care, surgical, and joint treatment applications, strengthening the company's intellectual pro…
Generate Biomedicines and Roswell Park Comprehensive Cancer Center have initiated a Phase 1 clinical trial for GB-5267, an investigational AI-designed IL-18 armored CAR T-cell therapy aimed at treating platinum-resistant ovarian cancer by targeting the MUC16 antigen. The approach focuses on overcoming solid tumor microenvironment challenges without…
Kyntra Bio announces the appointment of Andrew E. Singer, MBA, a seasoned biotechnology finance and strategy executive, to its Board of Directors and Audit Committee. The move aims to leverage Mr. Singer's extensive expertise to advance the company's rare disease and oncology pipeline and support strategic priorities. Concurrently, long-serving boa…
Iovance Biotherapeutics announces the appointment of Dr. Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer to lead clinical development efforts for its tumor infiltrating lymphocyte (TIL) therapies in multiple solid tumor cancers. Dr. Berkowitz brings extensive experience in cancer drug development and regulatory approvals, previously holding l…
Monte Rosa Therapeutics announced positive results from its GFORCE-1 Phase 1 study of MRT-8102, a NEK7-directed molecular glue degrader targeting inflammatory pathways linked to atherosclerotic cardiovascular disease (ASCVD). In obese subjects with elevated cardiovascular risk, MRT-8102 demonstrated robust NEK7 degradation and significant reduction…
Medifast's Trilivy metabolic health system identifies five often overlooked signs of poor metabolic health and offers a structured framework, incorporating its MetaVantage Reset Formula and coaching support, to improve metabolic outcomes. A clinical trial showed 14% reduction in visceral fat and 98% lean mass retention over 16 weeks, supporting the…
Fervo Energy announced that its first GeoBlock at Cape Station in Utah achieved commercial operation ahead of schedule, generating 33 MW of net power and starting revenue under its power purchase agreement. This milestone establishes Fervo's leadership in enhanced geothermal systems (EGS) and signals the viability of reliable, carbon-free power pro…
Fate Therapeutics announced that its management will participate in major healthcare investor conferences in the fourth quarter of 2026, including the Jefferies Global Healthcare Conference in London and the Piper Sandler Annual Healthcare Conference in New York. The company focuses on developing induced pluripotent stem cell-derived cellular immun…
Shattuck Labs, a biotech company focused on inflammatory and immune-mediated diseases, announced plans to start a Phase 2 clinical trial in 2026 to evaluate its drug candidate SL-325 for moderate to severe hidradenitis suppurativa (HS). The company also appointed Dr. Shoba Ravichandran as Senior Vice President of Clinical Development to lead this p…
Foghorn Therapeutics, trading as FHTX on Nasdaq, announced it will discontinue the FHD-909 and Selective SMARCA2 degrader programs following unsatisfactory clinical trial results in collaboration with Lilly. The company plans to redirect resources towards its proprietary pipeline including EP300 and CBP degrader programs, and an oral immunology and…
Ocular Therapeutix, Inc. announced its participation in several key scientific and investor conferences throughout October 2026. The company plans to present updates on its late-stage clinical trials for AXPAXLI (OTX-TKI), an investigational axitinib intravitreal hydrogel for wet AMD and diabetic retinal diseases, alongside discussions of its comme…
TELUS Digital presents a comprehensive AI-driven approach to enhancing contact center operations through integrated capabilities including agent assist, automated quality monitoring, coaching optimization, and customer experience insights. Their proprietary Fuel iX™ platform demonstrates improved agent proficiency and customer satisfaction by creat…
Synopsys' recent investor messaging and deal activity suggest revenue and margin trajectories above current sell-side models. At a $450 print and an $83B market cap, the stock still looks buyable for a disciplined long with a $540 target and $385 stop, keyed to execution on AI/IP demand and persistent free cash flow generation.
Imperial Brands (IMBBY) is trading near its 52-week low with a 6.7% yield, single-digit-ish valuation (PE ~11.3) and oversold technicals (RSI ~31). That combination offers a tactical long entry for a mid-term swing trade if price stabilizes near $32. This idea lays out a clear entry, stop and target with catalysts and risks to watch.
TransUnion will release its financial results for Q3 2026 on October 27, 2026, followed by a conference call to discuss the results. The company highlights its global operations and growth in credit information, marketing, fraud, risk, and analytics solutions.
FUJIY is a buy here. Management's decision to sell a non-core business and spin off another creates a near-term rerating opportunity: the stock trades at $10.55 with a $26.0B market cap, a modest 15x PE and 1.05x PB. With improving healthcare/biotech exposure, attractive semiconductor materials tailwinds, and technicals showing constructive momentu…
Brown & Brown, Inc., a leading insurance brokerage firm, announced that it will release its 2026 third-quarter earnings after market close on October 26, 2026, followed by a conference call with key executives on October 27. The company provides an invitation for investors to participate in or listen to the webcast and highlights that the earnings …
Kailera Therapeutics disclosed new Phase 1 clinical data for ribupatide injection, demonstrating flexibility in injection sites without compromising bioavailability or safety. Additionally, partner Hengrui Pharma presented encouraging data for multiple GLP-1-based obesity treatments, including the tri-agonist KAI-4729 showing significant weight and…
National Fuel Gas Company has finalized the acquisition of CenterPoint Energy's Ohio natural gas utility, Vectren Energy Delivery of Ohio, LLC, which will be renamed National Fuel Gas Distribution of Ohio, LLC. This acquisition nearly doubles National Fuel’s utility rate base, expands operations into Ohio, and adds approximately 335,000 new custome…
Descartes Systems Group's customs compliance platform, Descartes Thyme™, has powered Manifests Ireland's growth from 20,000 to 2 million annual customs declarations since Brexit. This long-term partnership has enabled Manifests Ireland to automate complex customs processes, maintain compliance, and expand operations into new European markets with e…
Brookfield announced the final close of Oaktree's Asset-Backed Finance Fund (ABF I) at $2 billion, hitting its fundraising target with commitments from global institutional investors. The fund will provide flexible capital across sectors such as equipment leasing, transportation, consumer finance, real estate, and infrastructure. This close complem…
